DOI: 10.1055/s-00034913



Beyer-Westendorf J, Schellong MS, Gerlach H, Rabe E, Weitz JI, Jersemann K, Sahin K, Bauersachs R.
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.

Lancet Haematol 2017; Mar;
04 (03) e105-e113.

Download Bibliographical Data